Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) Institutional Ownership
CUSIP: 005083100
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
44
Shares (Excl. Options)
13,110,237
Price
$6.12
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- ACTU on Nasdaq
- Shares outstanding
- 23,165,208
- Price per share
- $2.76
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 13,110,237
- Total reported value
- $80,234,480
- % of total 13F portfolios
- 0%
- Share change
- +1,089,796
- Value change
- +$6,660,093
- Number of holders
- 44
- Price from insider filings
- $2.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 005083100.
- 44 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 44 to 4 between Q4 2025 and Q1 2026.
- Reported value moved from $80,234,480 to $843.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 44 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 005083100?
CUSIP 005083100 identifies ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue With The Right Next Step
- Latest 13F filings - identify new institutional portfolio moves.
- Latest Schedule 13D/13G reports - cross-check beneficial ownership events.
- All institutional ownership pages - compare nearby CUSIPs and holder concentration.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 005083100:
Significant Owners of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOS Fund I, LP | 50% | -2.9% | $112,734,207 | +$1,733,259 | 10,267,232 | +1.6% | AARON G.L. FLETCHER | 27 Jun 2025 |
| Voss Capital, LP | 5.3% | $8,471,516 | 1,227,756 | Voss Capital, LP | 15 Dec 2025 |
As of 31 Dec 2025, 44 institutional investors reported holding 13,110,237 shares of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU). This represents 57% of the company’s total 23,165,208 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 43% | 10,049,996 | 0% | 74% | $61,505,976 |
| Voss Capital, LP | 5.6% | 1,300,000 | +45% | 0.42% | $7,956,000 |
| VANGUARD GROUP INC | 2.3% | 529,111 | +67% | 0% | $3,238,159 |
| BlackRock, Inc. | 1.9% | 432,041 | +53% | 0% | $2,644,091 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.9% | 207,744 | +43% | 0% | $1,271,393 |
| NORTHERN TRUST CORP | 0.44% | 101,423 | +19% | 0% | $620,709 |
| Texas Capital Bank Wealth Management Services Inc | 0.41% | 94,592 | 0.03% | $578,903 | |
| STATE STREET CORP | 0.24% | 56,290 | +13% | 0% | $344,495 |
| ROYAL BANK OF CANADA | 0.15% | 35,187 | +173% | 0% | $215,000 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.13% | 30,982 | 0% | $189,610 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.1% | 23,841 | +61% | 0% | $145,907 |
| Rock Creek Group, LP | 0.09% | 21,759 | 0.02% | $133,165 | |
| WELLS FARGO & COMPANY/MN | 0.09% | 20,146 | +49% | 0% | $123,294 |
| SFMG, LLC | 0.09% | 20,000 | +18% | 0.01% | $122,400 |
| Gleason Group, Inc. | 0.08% | 19,028 | 0% | 0.01% | $116,451 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0.08% | 18,518 | -4.1% | 0% | $113,330 |
| JANE STREET GROUP, LLC | 0.07% | 16,625 | 0% | $101,745 | |
| BARCLAYS PLC | 0.06% | 14,946 | +69% | 0% | $91,470 |
| MORGAN STANLEY | 0.06% | 13,119 | +72% | 0% | $80,289 |
| LPL Financial LLC | 0.06% | 12,965 | -20% | 0% | $79,346 |
| Bank of New York Mellon Corp | 0.05% | 12,565 | 0% | $76,898 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | 10,253 | 0% | $62,748 | |
| RHUMBLINE ADVISERS | 0.04% | 9,534 | +8.7% | 0% | $58,343 |
| DEUTSCHE BANK AG\ | 0.04% | 9,309 | +640% | 0% | $56,971 |
| BANK OF AMERICA CORP /DE/ | 0.04% | 9,061 | +86% | 0% | $55,454 |
Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 308 | $843 | +$840 | $2.76 | 4 |
| 2025 Q4 | 13,110,237 | $80,234,480 | +$6,660,093 | $6.12 | 44 |
| 2025 Q3 | 12,026,097 | $80,455,749 | +$5,410,880 | $6.69 | 42 |
| 2025 Q2 | 11,217,203 | $68,541,901 | +$4,868,272 | $6.11 | 38 |
| 2025 Q1 | 10,401,592 | $70,445,498 | +$1,934,199 | $6.77 | 25 |
| 2024 Q4 | 10,116,136 | $80,524,037 | -$1,087,916 | $7.96 | 19 |
| 2024 Q3 | 382,167 | $2,847,155 | +$2,847,155 | $7.45 | 10 |